Bleeding disorders are a group of disorders that share the inability to form a proper blood clot. Improper clotting can be caused by defects in blood components such as platelets and/or clotting proteins, also called clotting factors. Symptoms of a bleeding disorder include: Bleeding into joints, muscles and soft tissues, Excessive bruising, Prolonged, heavy menstrual periods (menorrhagia) There were 45,785 patients in the Noraway Alone in 2012-13.
A total of $202.2 million was expended by governments on clotting factor products in 2012-13. A total of 25,177,750 IU of recombinant Factor IX products were used by Haemophilia B patients in 2012-13. Many people with bleeding disorders are treated at haemophilia treatment centres (HTCs) which are specialist centres that provide comprehensive care to people with haemophilia and similar conditions. The comprehensive care model ensures that preventative and general treatment on the complex aspects of haemophilia are given in a coordinated way by a multi?disciplinary team within the one centre.
Many of today's standards of research are based upon what was learned from clinical trials in the past such as reducing complications of clots, what causes clots. Some bleeding disorders, such as hemophilia, can be inherited or acquired. Others can occur from such conditions as anemia, cirrhosis of the liver, HIV, leukemia and vitamin K deficiency, lot of research is being done on these topics.